Of the 500 cases, 125 (25%) suffered from a systemic embolus. Thirty-seven of these (30%) had more than one embolus, the total number of embolic episodes being 173. Twenty-seven per cent of the group were men and 73% were women. The overall frequency of emboli was 25% for both men and women. Figure 1 shows the age at the time of the first embolus. It is apparent that while the maximum incidence is between the ages of 40 and 50 years, thirty-one of the patients were under the age of 40 and seven were under the age of 30 years. The increasing embolic incidence with age is associated with a rise in the incidence of atrial fibrillation. The group.bmj.com on May 4, 2017 -Published by http://pmj.bmj.com/ Downloaded from
Summary
Over a period of 9i years patients in East Anglia with mitral valve disease not requiring immediate surgery have been followed. There has been a high incidence of systemic embolism before the patients are referred.
Long-term treatment with anticoagulants appears to offer a good degree of protection to these patients and, provided the control of the treatment is good, the risks arising from it are small and less than the risks of embolism.
SYSTEMIC arterial embolism is a serious complication of mitral disease. The morbidity, the recurrence rate and the mortality are all considerable. Prevention of this disaster is the ideal to be aimed at. Early in the 1960s, one of the present authors was impressed by the number of patients seen with relatively mild mitral valve disease or a perfectly operable valve, who had yet suffered from disastrous emboli before they were referred. Since then anticoagulants have been used widely in this group of patients in this Unit and since 1962 they have been used in any patient with more than trivial mitral stenosis. A year or two later this usage was extended to mitral incompetence also, provided it was more than trivial. Anticoagulants were used irrespective of the rhythm of the patient. However, new patients with what we believe are preventable emboli are still being seen with some frequency and we feel that this is still a neglected subject.
After 10 years the place of anticoagulants in the prevention of emboli has still not been fully established. In any case the efficiency of anticoagulant control varies greatly from one area to another and it therefore seemed important to determine precisely what the results on this Unit were. In particular answers to the following questions were sought:
(1) How necessary were anticoagulants? (2) How effective were they? (1959) .
Systemic embolization
Of the 500 cases, 125 (25%) suffered from a systemic embolus. Thirty-seven of these (30%) had more than one embolus, the total number of embolic episodes being 173. Twenty-seven per cent of the group were men and 73% were women. The overall frequency of emboli was 25% for both men and women. Figure 1 shows the age at the time of the first embolus. It is apparent that while the maximum incidence is between the ages of 40 and 50 years, thirty-one of the patients were under the age of 40 and seven were under the age of 30 years. The increasing embolic incidence with age is associated with a rise in the incidence of atrial fibrillation. The importance of emboli occurring in the relatively young group is stressed.
Cardiac rhythm
Twenty-four of the embolic patients were in sinus rhythm. None of these patients gave any history of paroxysmal dysrhythmia. This provides 19% of the total embolic series and is an incidence of 11 % of the patients in sinus rhythm. In the fibrillating group 35% suffered emboli. This incidence of patients in sinus rhythm is far from insignificant. Size of the left atrial appendix Somerville & Chambers (1964) suggested that the incidence of embolism was related to the size of the left atrial appendix. This did not appear to be so in our series. We looked at forty-seven patients in whom a chest X-ray was available within 3 months of embolism and in whom there had been no previous cardiac surgery. The atrial size was graded 0-4 and the results are shown in Table 4 . There were eighteen cases of minor bleeding such as vaginal bleeding or epistaxis. It could be considered that these were an aggravation of bleeding rather than actual haemorrhage initiated by anticoagulants.
Details of more significant haemorrhages are given in Table 5 . (1954) recorded an incidence of 13% in his whole series and noted that 75% of the emboli were cerebral with resultant disastrous effect. In 12-5% of the embolic cases embolism was the first symptom-often occurring when there was no effort intolerance and the lesion was relatively mild. He also noted that patients with mitral incompetence were not free from emboli and 9-7y% of them suffered emboli. Bannister (1960) followed up 105 of Wood's mitral stenotic patients in whom valvotomy had been deferred because of the mildness of the lesion and he found that twenty-two of these had emboli, fifteen of which were cerebral, five of them causing death. He estimated that for patients under the age of 40 and in sinus rhythm the risk of embolus was 5%.
Fleming & Wood (1959) Hutchinson & Stock (1963) studied paroxysmal cerebral ischaemia in patients with rheumatic heart disease. Three hundred and twenty-three such patients were reviewed for neurological symptoms and it was found that there had been sixty classical cerebral embolic episodes in forty-four patients (14% of the series). Thirty-eight patients (12%) gave a history of disabling recurrent neurological disturbances. These attacks were not uncommon in patients with sinus rhythm. Swash & Earl (1970) particularly sought a history of transient visual obscuration and found that 33Y%
were patients with rheumatic heart disease. None of these spontaneously complained of symptoms. They seemed to be embolic in nature, possibly from platelet aggregation. Thirty-five percent of the patients in atrial fibrillation and 30Y% in sinus rhythm had the symptoms. Anticoagulant treatment appeared to diminish the incidence. Cleland et al. (1969) noted that embolism is common in the absence of prophylactic treatment and they found an incidence of 42% in 155 patients followed for 10 years. They mention that it usually occurs in the presence of atrial fibrillation but may be found in sinus rhythm. Coulshed et al. (1970) reported a very detailed study of systemic embolism in mitral valve disease dealing with 737 cases of mitral stenosis and 102 cases of mitral incompetence. The embolic incidence increased with age and with atrial fibrillation but was not related to disability. In mitral stenosis with sinus rhythm there was an 8% incidence and in atrial fibrillation it was 31-5%. In mitral incompetence in sinus rhythm the incidence was 0-7% and in atrial fibrillation 22%. Of the 157 with emboli 20% were in sinus rhythm. In 166 non-surgical patients with mitral stenosis the embolic incidence was 3-7%o per patient-year with seven embolic deaths. Multiple emboli occurred in seventy-nine patients, twenty-four having more than one recurrence. Seven of these were in sinus rhythm. They note particularly that embolism is as common in mitral incompetence as in mitral stenosis, and where sinus rhythm is present valvotomy has no effect on the embollc incidence. Also, unless valvotomy was indicated on haemodynamic grounds, it had no beneficial effect on the incidence of emboli.
Is there any way of selecting patients who are particularly at risk? Somerville & Chambers (1964) suggested that the incidence of embolism is directly related to the size of the left atrium and particularly its appendix. However, a number of other studies such as the present one and that of Coulshed et al. (1970) have failed to verify this. In any case, 14% of their embolic series had a small left atrial appendix.
While statistically age, atrial fibrillation, size of the left atrium and appendix, low cardiac output and cardiomegaly increase the risk of embolism many of the patients will fall outside these parameters. It therefore seemed that all patients with more than trivial mitral valve disease should be considered for protection without waiting for emboli to occur.
The administration of anticoagulants on a longterm basis seemed the only possibility. Wood & Conn (1954) describe seven embolic cases of mitral stenosis they treated. They found that emboli recurred when treatment was withdrawn and suggested that it should be continued indefinitely. Askey & Bernstein (1960) emphasize that while 25-30% of adults with rheumatic heart disease die of embolism there is an even greater incidence of disability. Again they report that embolism is frequently the first sign in an otherwise well patient. They suggest that moderate treatment with anticoagulants decreases this risk. Lillicrap & Piesowicz (1964) made a similar suggestion, also noting that the occurrence of embolism is not an additional reason for mitral valvotomy. Szekely (1964) reported a very thorough study of 754 patients with chronic rheumatic heart disease followed over a period of 5833 patient-years. He noted that emboli were seven times more common in atrial fibrillation than in sinus rhythm and that where the duration of the fibrillation was known one-third of the emboli occurred within 1 month and two-thirds within 12 months of the onset of fibrillation. This study emphasizes that emboli can occur in young symptom-free patients in sinus rhythm with mild mitral valve disease, and that long term anticoagulant treatment can be used to reduce the incidence of emboli with little resultant risk to the patient provided the control of the treatment is carried out with due care.
It is disturbing to find that patients are still having emboli before they are referred and that advice about anticoagulants (as in Case 5) is not always accepted by the referring physician. We therefore consider that anticoagulants are very necessary. That they are effective is indicated by the fact that in the 91-year period of the study only five emboli occurred in the medical cases of mitral valve disease who were on anticoagulants. The relative safety is indicated by the lack of serious complications, and a minor complication rate of 2-3% per patient-treatment-year over the whole series and 0-2% with good control on warfarin.
Finally we consider that we should not be more restricted in our use of anticoagulants to patients with more than trivial mitral valve disease. Youth, sinus rhythm and a small left atrium offer no absolute protection against embolus. The greatest difficulty arises in deciding about the milder cases, and in these other aspects of the patient's life or personality may sway the decision. Patients with a simple mitral presystolic murmur or with a mitral late or pansystolic murmur have not been treated, but most others have.
